SPC342
Trastusúmab deruxtekan
Status:
VeittApplication date:
6.7.2021Application published:
15.7.2021Grant published:
15.7.2023
Max expiry date:
19.1.2036Medicine name:
EnhertuMedicine for children:
No
Timeline
Today
6.7.2021Application
15.7.2021Publication
15.7.2023Registration
19.1.2036Expires
Marketing license
IS authorization number:
EU/1/20/1508/001Date:
28.1.2021
Foreign authorization number:
EU/1/20/1508Date:
18.1.2021
Owner
Name:
Daiichi Sankyo Company, LimitedAddress:
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3101032